Trial Profile
Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 20 Apr 2016 Status changed from recruiting to completed.
- 22 Apr 2015 New trial record